Thursday, July 3, 2025
HomeIndustriesHealthcare

Healthcare

Sumitomo Pharma Oncology Receives Orphan Drug Designation for DSP-0390

Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, announced the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation...

Werfen Receives US FDA 510(K) Clearance for Rotem Sigma Thromboelastometry System

Werfen announced the 510(k) clearance of the ROTEM sigma Thromboelastometry System by the US Food and Drug Administration (FDA). The ROTEM sigma delivers real-time,...

Hansa Biopharma Announces $70 Million Non-dilutive Product Finance Transaction With Novaquest

Hansa Biopharma AB, a pioneer in enzyme technology for rare immunological conditions, announces that the Company has entered into an agreement with U.S.-based NovaQuest...

RegeneRx Partner Signs LOI with Global Ophthalmology CRO for Two Phase 3 Clinical Trials in Neurotrophic Keratitis

RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair, and regeneration, is reporting today that its U.S. joint venture (JV)...

Medicare Extends Coverage of Natera’s Signatera MRD Test to Muscle Invasive Bladder Cancer

Natera, Inc., a global leader in cell-free DNA testing, announced that it has received written confirmation from the CMS Molecular Diagnostics Services Program (MolDX)...
0FansLike
0FollowersFollow
spot_img

Hot Topics